Prosecution Insights
Last updated: July 17, 2026
Application No. 17/703,976

Enhancement of Focus and Concentration by Combination of Flashing Light, Sound, and/or Binaural Beats to Stimulate Neural Oscillations in the Neocortex and Facilitate Training and Learning

Non-Final OA §103§112
Filed
Mar 24, 2022
Priority
Sep 11, 2018 — CIP of 16/128,487 +1 more
Examiner
DORNA, CARRIE R
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Alzheimer'S Light LLC
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
655 granted / 908 resolved
+2.1% vs TC avg
Strong +28% interview lift
Without
With
+28.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
33 currently pending
Career history
944
Total Applications
across all art units

Statute-Specific Performance

§101
2.8%
-37.2% vs TC avg
§103
53.7%
+13.7% vs TC avg
§102
13.5%
-26.5% vs TC avg
§112
20.2%
-19.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 908 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 12-31 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected inventions, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 29 December 2025. Claim Objections Claims 1 and 11 are objected to because of the following informalities: Claim 1, line 4: “a portion of background” should read --a portion of a background— Claim 11, line 9: “is adjacent or the second” should read --is adjacent to the second--. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “allowing user to engage” yet previously recites “a human user”. It is unclear whether the second recitation is intended to reference the same user. The examiner suggests amending “allowing user to engage” to read --allowing the user to engage-- to overcome this rejection. Claim 9 recites “allows user to engage” while parent claim 1 recites “a human user”. It is unclear whether applicant intends to reference the same user. The examiner suggests amending “allows user to engage” to read --allows the user to engage-- to overcome this rejection. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-4, 6, 7, and 9-11 are rejected under 35 U.S.C. 103 as being unpatentable over WO 2015/068168 (Vadai et al.) in view of U.S. Patent Application Publication No. 2017/0143934 (Tsai et al.). Regarding claims 1 and 4, Vadai teaches a method of treatment of Alzheimer's disease, stroke, dementia, ADHD, ASD, dyslexia, dyscalculia, dysgraphia, Down syndrome, conduct disorder, emotional or behavioral disorder, speech cluttering, stuttering, language disorders, or deficit of attention in a human user (abstract; “[t]he invention may apply to several medical conditions”, [02]-[03], [12]-[16], [19], “amblyopia, strabismus, glaucoma, Parkinson’s disease, Alzheimer, other brain diseases and conditions”, [26]), comprising: every t seconds showing on at least a portion of background of a screen a fixed or changing lighter image or color for x% of the t seconds and a fixed or changing darker image or color for y% of the t seconds (images flicker or vary in brightness, [79]-[80]; see also [69], [109]); showing on the foreground of the screen a cognitive image challenge allowing user to engage in cognitive training or in cognitive activity (overlay images present passive visual learning, [60]); and delivering to the user sound or sound bursts ([77]), wherein the lighter image is on average more bright than the darker image or color (images flicker or vary in brightness, [79]-[80]). Vadai does not specify the frequency and duration of the presentation of the lighter and darker images or colors, and does not specify the frequency of the sound. However, Tsai teaches a method of treatment of Alzheimer’s disease or dimension in a human user (abstract; [0009]), comprising: every t seconds showing a lighter color for x% of the t seconds and a darker color for y% of the t seconds, wherein t is 1/f wherein f is between 30 Hz and 50 Hz, wherein x is greater than 0% and less than 100%, and wherein y is greater than 0% and less than 100% ([0303]; 40 Hz dark/light flicker with 50% light, 50% dark, [0452]). Tsai teaches the method additionally includes delivering sound at a frequency of about 40 Hz (abstract; method for treating dementia includes delivery of light and/or sound at 40 Hz, [0011]; sound at about 40 Hz, [0195]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Vadai to include delivery of sound at about 40 Hz, and wherein t is 1/f wherein f is between 30 Hz and 50 Hz, such as 40 Hz, wherein x is greater than 0% and less than 100%, such as 50%, and wherein y is greater than 0% and less than 100%, such as 50%, as taught by Tsai in order to induce “in vivo gamma oscillations in at least one brain region” of the user to prevent, mitigate, or treat dementia ([0011]). Regarding claims 2 and 3, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai as modified teaches f is 40 Hz (see rejection of claim 1; Tsai: [0011], [0303], [0452]). Vadai further teaches the visual stimulation parameters including “brightness, contrast, saturation” may be varied ([31]; [67]). Vadai as modified does not expressly teach x is 66% and y is 33% or that x is 33% and y is 66%. However, Tsai teaches an alternative embodiment wherein the on/off duty cycle of the light flicker may be varied from x, y = 50%, such that x and y are not equal (white (on) and black (off) in 40 Hz light flicker 5502, [0303]-[0304], see Figure 55A). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the on/off cycle of the light of Vadai as modified such that x is 33% and y is 66% or x is 66% and y is 33% in light of the teachings of Tsai in order to meet the treatment needs of an individual user, wherein the optimal x and y values are discoverable through routine experimentation. It has been held that "where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955), see MPEP 2144.05(II)(A). Applicant appears to place no criticality on the values of x is 33% and y is 66% or x is 66% and y is 33%. Regarding claims 6 and 7, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai teaches the screen is connected to or part of a computer device ([90]); wherein the computer device is capable of receiving the user’s input (“alternation of the display properties may be triggered by either command signal delivered to the display from a controller (for example an computer or a Smartphone)”, [68]). Regarding claim 9, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai teaches the lighter image or the darker image allows the user to engage in cognitive training or in cognitive activity (overlay images present passive visual learning, [60]) Regarding claim 10, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai teaches the lighter image or the darker image is a video (“superimposed to the video content presented”, [60]). Regarding claim 11, Vadai teaches a method of treatment of Alzheimer's disease, stroke, dementia, ADHD, ASD, dyslexia, dyscalculia, dysgraphia, Down syndrome, conduct disorder, emotional or behavioral disorder, speech cluttering, stuttering, language disorders, or deficit of attention in a human user (abstract; “[t]he invention may apply to several medical conditions”, [02]-[03], [12]-[16], [19], “amblyopia, strabismus, glaucoma, Parkinson’s disease, Alzheimer, other brain diseases and conditions”, [26]), comprising: every t seconds showing on at first at least a portion of background of a first screen a fixed or changing lighter image or color for x% of the t seconds and a fixed or changing darker image or color for y% of the t seconds (binocular device, [69]; images flicker or vary in brightness, [79]-[80]; see also [69], [109]); showing an image allowing the user to engage in cognitive training or in cognitive activity on a second at least a portion of a second screen (overlay images present passive visual learning, [60]; overlay images presented dichoptically, [77], on binocular device, [69]); and delivering to the user sound or sound bursts ([77]), wherein the first at least a portion of the first screen is adjacent to the second at least a portion of the second screen (binocular device, [69]; Figure 3); wherein the lighter image is on average more bright than the darker image or color (images flicker or vary in brightness, [79]-[80]). Vadai does not specify the frequency and duration of the presentation of the lighter and darker images or colors, and does not specify the frequency of the sound. However, Tsai teaches a method of treatment of Alzheimer’s disease or dimension in a human user (abstract; [0009]), comprising: every t seconds showing a lighter color for x% of the t seconds and a darker color for y% of the t seconds, wherein t is 1/f wherein f is between 30 Hz and 50 Hz, wherein x is greater than 0% and less than 100%, and wherein y is greater than 0% and less than 100% ([0303]; 40 Hz dark/light flicker with 50% light, 50% dark, [0452]). Tsai teaches the method additionally includes delivering sound at a frequency of about 40 Hz (abstract; method for treating dementia includes delivery of light and/or sound at 40 Hz, [0011]; sound at about 40 Hz, [0195]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Vadai to include delivery of sound at about 40 Hz, and wherein t is 1/f wherein f is between 30 Hz and 50 Hz, such as 40 Hz, wherein x is greater than 0% and less than 100%, such as 50%, and wherein y is greater than 0% and less than 100%, such as 50%, as taught by Tsai in order to induce “in vivo gamma oscillations in at least one brain region” of the user to prevent, mitigate, or treat dementia ([0011]). Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over WO 2015/068168 (Vadai et al.) in view of U.S. Patent Application Publication No. 2017/0143934 (Tsai et al.) as applied to claim 1 above, and further in view of U.S. Patent Application Publication No. 2012/0071706 (Martin). Regarding claim 5, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai as modified does not specify the screen is a TV screen. However, Martin teaches a method of treatment for reduction in agitation in Alzheimer’s patients (abstract; [0015]), comprising presenting visual stimuli to a user, wherein the visual stimuli is presented on a TV screen ([0038]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to provide the TV screen of Martin as the screen of Vadai as modified, as Martin teaches various display devices, such as a computer monitor and television, are substitutable alternatives for presenting therapeutic visual stimuli to a user ([0038]). Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over WO 2015/068168 (Vadai et al.) in view of U.S. Patent Application Publication No. 2017/0143934 (Tsai et al.) as applied to claim 1 above, and further in view of U.S. Patent Application Publication No. 2018/0133507 (Malchano et al.). Regarding claim 8, Vadai in view of Tsai teaches all the limitations of claim 1. Vadai as modified does not specify the at least a portion of the screen is the entire screen. However, Malchano teaches a method of treating Alzheimer's disease in a human user ([0004]), comprising: every t seconds showing on an entire screen a fixed lighter image or color for x% of the t seconds and a fixed darker image or color for y% of the t seconds, where t is 1/f, and f is 40 Hz (tablet 500 screen 305 is enabled (light) Fig. 5A or disabled (dark) Fig. 5B to flash at a frequency of 40 Hz, [0283]-[0284]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Vadai as modified such that the at least a portion of the screen is the entire screen as taught by Malchano, in order to expand the visual field perceived by the user for stimulation to effectively treat Alzheimer’s disease (Malchano: entire screen, [0283]-[0284]; [0004]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Carrie R Dorna whose telephone number is (571)270-7483. The examiner can normally be reached 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at 571-272-4233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CARRIE R DORNA/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Mar 24, 2022
Application Filed
May 11, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678632
APPARATUS AND METHOD FOR GENERATING A MAGNETIC FIELD
4y 6m to grant Granted Jul 14, 2026
Patent 12673214
LESS INVASIVE AND IMPROVED PERIPHERAL NERVE STIMULATORS FOR OBSTRUCTIVE SLEEP APNEA AND OTHER APPLICATIONS
3y 11m to grant Granted Jul 07, 2026
Patent 12673179
REHABILITATION ASSISTANT SYSTEM FOR PATIENTS WITH DEPRESSION
3y 10m to grant Granted Jul 07, 2026
Patent 12667520
Acupuncture device and method of using magnetic fields to stimulate acupuncture needles, and magnetic coil configurations
4y 1m to grant Granted Jun 30, 2026
Patent 12667508
Shield Assemblies For Use With Patient Support Apparatuses
3y 8m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+28.1%)
3y 4m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 908 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month